Sentry Hill Partners

Sentry Hill Partners is a strategic advisory and investment firm dedicated to the biotechnology and life sciences sectors. Founded in 2022 by Dr. John Maraganore, the former founding CEO of Alnylam Pharmaceuticals, the firm provides high-level consultancy to emerging biotech companies, venture capital firms, and academic institutions. Sentry Hill Partners focuses on advancing innovative therapeutic modalities, including RNA-based medicines, gene therapies, and other platform technologies. The firm plays a pivotal role in shaping the strategy and governance of numerous high-growth startups through board memberships and executive mentorship. Based in the Boston area, Sentry Hill Partners leverages Dr. Maraganore's extensive industry experience to bridge the gap between scientific innovation and commercial success.